Analysis of the cellular functions of PTEN using catalytic domain and C-terminal mutations: differential effects of C-terminal deletion on signallingpathways downstream of phosphoinositide 3-kinase
Nr. Leslie et al., Analysis of the cellular functions of PTEN using catalytic domain and C-terminal mutations: differential effects of C-terminal deletion on signallingpathways downstream of phosphoinositide 3-kinase, BIOCHEM J, 346, 2000, pp. 827-833
The tumour suppressor protein, PTEN (phosphatase and tensin homolog deleted
on chromosome in), is a phosphatase that can dephosphorylate tyrosine-cont
aining peptides, She, focal adhesion kinase and phosphoinositide substrates
. In cellular assays, PTEN has been shown to antagonize the PI-3K-dependent
activation of protein kinase B (PE;B) and to inhibit cell spreading and mo
tility. It is currently unclear, however, whether PTEN accomplishes these e
ffects through its lipid- or protein-phosphatase activity, although strong
evidence has demonstrated the importance of the latter for tumour suppressi
on by PTEN. By using a PTEN G129E (Gly(120) --> Glu) mutant that has lost i
ts lipid phosphatase activity, while retaining protein phosphatase activity
, we demonstrated a requirement for the lipid phosphatase activity of PTEN
in the regulation of PKB activity, cell viability and membrane ruffling. We
also made a small C-terminal deletion of PTEN, removing a putative PDZ (PS
D95, Dig and ZO1)-binding motif, with no detectable effect on the phosphata
se activity of the protein expressed in HEK393 cells (human embryonic kidne
y 293 cells) assayed in vitro. Surprisingly, expression of this mutant reve
aled differential requirements for the C-terminus in the different function
al assays. Wild-type and C-terminally deleted PTEN appeared to be equally a
ctive in down-regulating PE;B activity, but this mutant enzyme had no effec
t on platelet-derived growth factor (PDGF)-induced membrane ruffling and wa
s only partially active in a cell viability assay. These results stress the
importance of the lipid phosphatase activity of PTEN in the regulation of
several signalling pathways. They also identify a mutation, similar to muta
tions that occur in some human tumours, which removes the effect of PTEN on
membrane ruffling but not that on PKB.